Partner Content Partner Content Explore innovative approaches and novel targets in analgesic... The opioid crisis has cost the economy $1 trillion since 2001 in the USA alone, and the prospect does not look like it will get better any time soon.
News Troubled Mallinckrodt pays $1.2bn for Sucampo Specialist pharma company Mallinckrodt announced on 26 December that it is to acquire Sucampo Pharmaceuticals for around $1.2 billion.
News FDA encourages cheap abuse-deterrent painkillers Regulator waiting for non-opioid alternatives to reach the market
News Smartphone app looks to tackle US opioid crisis App gives US providers information to make informed medication decisions within regulatory guidelines.
News Pathos AI signs two cancer deals with Alphamab and AZ Pathos AI has grown its oncology pipeline by licensing a bispecific ADC from Alphamab for $125m and partnering a breast cancer drug from AstraZeneca.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.